Sinotau USA
Manufacturing · China · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Building 1 No.5 Tongji Middle Road Beiji...Phone Number
+86 1052805808Website
www.sinotau.comRevenue
$20.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sinotau USA
Sinotau Pharmaceutical Group (Sinotau) is headquartered in Beijing, China. The company was launched in 2004 with the initial goal to develop, manufacture and commercialize imported and local generic medicines in China. Since 2014, the company has extended its efforts into radiopharmaceutical development and commercialization in China, and through both licensing and in-house development the Company has implemented an imaging pipeline in the fields of oncology, neurodegenerative diseases and cardiovascular diseases, along with an oncology therapy (theranostics) pipeline.Explore more
Popular SearchesSinotau USASinoTauSinotau Pharmaceutical GroupBeijing Sinotau Pharmaceutical Technology Co. LtdSinotau Usa IncSIC Code 28,283NAICS Code 32,325Show moreSinotau USA Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sinotau USA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Sinotau USA recently announced quarterly report
Sinotau USA, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Sinotau USA
Funding: Get notified immidiatlly once Sinotau USA has new funding data
Check if Sinotau USA has recently received funding, and reach out quickly before it becomes old news!
Check out if Sinotau USA is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Sinotau USA launches new products
Click to see if Sinotau USA had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Sinotau USA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sinotau USA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sinotau USA.
Sinotau USA financials insights
Gather financial insights about Sinotau USA, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Other Financing Round
$153.8M
Sinotau USA Tech Stack
A closer look at the technologies used by Sinotau USA
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Sinotau USA News & Media
Blue Earth Diagnostics Ltd Collaborates with Sinotau Pharmaceutical Group to Bring Prostate Cancer PET Diagnostic Imaging Agent, Flotufolastat (18F) Injection, to China
OXFORD, England & MONROE TOWNSHIP, N.J.--(BUSINESS WIRE)--Blue Earth Diagnostics Ltd, a Bracco company and recognised leader in the development and commercialisation of innovative PET radiopharmaceuticals, announced that it has signed an exclusive strategic agreement with Sinotau Pharmaceutical Group for the positron emission tomography (PET) imaging agent flotufolastat (18F) injection (formerly referred to as 18F-rhPSMA-7.3) in prostate cancer. Under the terms of the agreement this will be a cCentrum Pharmaceuticals Secures Over CNY 1.1 Bn in New Financing Round | EqualOcean
Centrum Pharmaceuticals Secures Over CNY 1.1 Bn in New Financing RoundCerveau Technologies and Sinotau Pharmaceutical Group Announce Sinotau’s Achievement of a Major Milestone in China Strategy
BOSTON--(BUSINESS WIRE)--Sinotau Pharmaceuticals has announced today an agreement with HTA CO. LTD for launching a new β-amyloid imaging agent for Alzheimer’s disease in China. “This agreement will greatly contribute to the successful launch of future products in China. It is expected that this new product will be used to treat patients by delivering the latest diagnostic technologies as well as contributing to developing therapies for Alzheimer’s disease. Sinotau Pharmaceuticals is devoted to
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sinotau USA
Sign Up For FreeTo access detailed company insights
Sinotau Pharmaceutical Group (Sinotau) is headquartered in Beijing, China. The company was launched in 2004 with the initial goal to develop, manufacture and commercialize imported and local generic medicines in China. Since 2014, the company has extended its efforts into radiopharmaceutical development and commercialization in China, and through b... Read More
